K
Kiro
AI helping medical biology
About Kiro
Kiro.bio is a startup that leverages artificial intelligence (AI) to enhance medical biology. The company believes that medical biology is central to patient care. Its mission is to improve interactions between laboratories, healthcare professionals, and patients, enabling them to take their care further with the help of new technologies and AI.
Read full description
Since its inception, Kiro.bio has been committed to working with biologists, clinicians, and medical sector experts to build a more understandable, personalized, and relevant biology for the benefit of patients. The company offers a solution for biology laboratories and healthcare professionals.
Kiro.bio provides an easy, fast, and secure way for users to retrieve their biology reports with just a click. The documents are accessible anywhere, anytime, and on any device. The results are displayed in a new, visual, and interactive format, making it easier for users to understand their results.
The company also offers personalized services. Whether you are a patient or a healthcare professional, your laboratory provides you with a personalized experience. It allows you to learn more and go further with the results, depending on each individual's biological profile.
Kiro.bio places a high priority on data protection and privacy. The company adheres to the most rigorous national and European standards for its solution.
In terms of its business model, Kiro.bio likely generates revenue by charging laboratories and healthcare professionals for its AI-powered services.
At a glance
- Status
- Operational
- Founded
- 2019
- Headquarters
- Paris, France
- Employees
- 55
- Open positions
- 1
- Dealroom signal
- 62.3/100
- Industry
- Health
- Sub-industry
- BioTechnology, Health Platform
- Sector
- Biotech & Life Sciences, Testing, Biotechnology, Core AI, Workflow, biotech medtech and e-health, Observatoire Deeptech, French Tech 2030, Hard Tech, AI Applications
- Technology
- Artificial Intelligence
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES A✓Equity / VC | Mar 2023 | $15M | $61M | Kurma Partners · Propulia Capital · Bpifrance · Sofinnova Partners | ↗ |
| OtherOther financing | Oct 2019 | $0 | — | Bpifrance | — |
Growth signals
Latest recorded traffic for Kiro is 450K monthly website visits, down 15.1% over the last three months. Kiro's team declined 5.2% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
| Company | Headquarters | Status | Employees | Total funding | Valuation |
|---|---|---|---|---|---|
 THERAPANACEADevotion to Innovation, Compassion for Patients, Artificial Intelligence for Cancer Care |
Paris, France | Operational | 73 | $3.9M | $15M |
 HawkCellProvides magnetic resonance imaging services to healthcare professionals |
Lyon, France | Operational | |||
 CallyopeMonitoring brain health through speech |
Neuilly-sur-Seine, France | Operational | |||
 ArkhnHelp hospitals managing and leveraging their data |
Paris, France | Operational | |||
 Whitelab GenomicsAI platform for accelerating genomic medicine development |
Évry-Courcouronnes, France | Operational | |||
 AgenTDeveloping the first blood diagnosis to detect Alzheimer’s disease while it’s still in the silent phase |
Paris, France | Operational | |||
 Synapse MedicineArtificial intelligence platform to manage drugs prescription |
Bordeaux, France | Operational | |||
 BrightHeartAdvancing prenatal ultrasound screening with AI |
Paris, France | Operational |
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A4 investors entered at this stage
Sofinnova Partners
Kurma Partners
Propulia Capital
Bpifrance
Other known investors4 additional known investors
Agoranov
Olivier Rameil- SLSacha Loiseau
ZEBOX Ventures
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Kiro on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Kiro’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.